Advertisement
For treating recurrent ovarian cancer, it turns out that a platinum-based regimen will confer the greatest probability for a benefit. And so, typically, in someone who has a recurrence more than six months out, doctors will often use a platinum-based regimen. For those whose cancer recurs less than six months out, it’s less likely that a platinum drug will be effective.
Continue Learning about Ovarian Cancer
Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.